✦ LIBER ✦

Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines

✍ Scribed by Guido Jenster

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 55 KB
Volume: 191
Category: Article
ISSN: 0022-3417
DOI: 10.1002/1096-9896(200007)191:3<227::aid-path636>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of the orphan nuclear recepto

Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells

✍ Roberta M. Moretti; Marina Montagnani Marelli; Marcella Motta; Donatella Polizzi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Androgenic regulation of growth factor a

Androgenic regulation of growth factor and growth factor receptor expression in the cwr22 model of prostatic adenocarcinoma

✍ Russell B. Myers; Denise Oelschlager; Upender Manne; Patricia N. Coan; Heidi Wei 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 314 KB 👁 2 views

The effects of androgen manipulation on epidermal growth factor (EGF) receptor, p185 erbB-2 and transforming growth factor-␣ (TGF-␣) levels were examined in prostatic adenocarcinoma. Male nude mice were inoculated with the CWR22 androgen-dependent human prostatic tumor or an androgenindependent (CWR

Dysregulated expression of growth factor

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

✍ Djakiew, Daniel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Differential activation of ErbB receptor

Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-? and epidermal growth factorin vivo

✍ Ezeh, Patrick I. ;Farbman, Albert I. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

Transforming growth factor-␣ (TGF-␣) and epidermal growth factor (EGF) are members of the EGF family of growth factors. They have a common receptor, the EGF receptor. This belongs to the tyrosine kinase group of receptors called the ErbB receptor family. Other members are ErbB-2, ErbB-3, and ErbB-4.

Inhibition of androgen-sensitive LNCaP p

Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: Association of antiproliferative action of the pineal hormone with mt1 receptor protein expression

✍ Si C. Xi; Stephanie W.F. Siu; Sze W. Fong; Stephen Y.W. Shiu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Luteinizing hormone-releasing hormone an

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

✍ Jungwirth, Andreas; Galvan, Georg; Pinski, Jacek; Halmos, Gabor; Szepeshazi, Kar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for